Published in Volume
116, Issue 5 (May 1, 2006)
J Clin Invest. 2006;116(5):1457–1457.
doi:10.1172/JCI24335C1.
Copyright © 2006, American Society for Clinical Investigation
Addendum
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
Stuart P. Weisberg, Deborah Hunter, Reid Huber, Jacob Lemieux, Sarah Slaymaker, Kris Vaddi, Israel Charo, Rudolph L. Leibel and Anthony W. Ferrante, Jr.
Published May 1, 2006
Original citation: J. Clin. Invest.
116:115-124 (2006). doi:10.1172/JCI24335
Citation for this addendum: J. Clin. Invest.
116:1457 (2006). doi:10.1172/JCI24335C1
During revision of reference 11 (Brodmerkel, C.M., et al. 2005. Discovery and pharmacological characterization of a novel rodent active CCR2 antagonist, INCB3344. J. Immunol. 175:5370-5378.), the structure of INCB3344 was omitted. The structure of INCB3344 follows:
